Frontlight ResearchEarly access
Trial site
Hospital Universitario Infanta Cristina
- 6running trials
- 8closed trials
The trials here
What the 14 trials at this site are about, from their registry records.
- Conditions
- Metastatic breast cancer4 trials
- Bladder cancer2 trials
- Lung cancer2 trials
- Childhood cancers1 trial
- Chronic kidney disease1 trial
- Heart failure1 trial
- Hepatitis B1 trial
- Kidney cancer1 trial
- Liver and biliary tract cancer1 trial
- Melanoma1 trial
- Obesity1 trial
- Ovarian cancer1 trial
- and 1 more
- Phase
- Phase 39 trials
- Phase 23 trials
- Status
- Completed7 trials
- Active, not recruiting5 trials
- Recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Abbott Medical Devices1 trial
- AbbVie1 trial
- AstraZeneca1 trial
- Boehringer Ingelheim1 trial
- Bristol Myers Squibb International Corporation1 trial
- and 9 more
Running trials
Recruiting
Active, not recruiting
OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer1 recruiting
Closed trials
Completed
Completed
Completed
Completed
Completed
Completed
Terminated
ODM-201 Maintenance Therapy in Patients With mCRPC Previously Treated With Novel Hormonal Agents.
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026